-
Additional file 3: of Meta-analysis of human gene expression in response to M...
List of the 85 GEO datasets available for TB-related host responses at the time of the study, their inclusion (color shaded) or exclusion in the meta-analysis and the reasons... -
dedup_wf_001--efb227cd3e5d48fa3510e16e948fcbb2
Predicted side effects of drugs. The list of 11,152 novel side effects of drugs spanning 39 drugs and 1,598 side effects. (XLSX 179 kb) -
Additional file 2: of Drug voyager: a computational platform for exploring un...
Predicted drug indications. The list of 1,816 novel drug indications spanning 47 drugs and 122 diseases. (XLSX 54 kb) -
dedup_wf_001--f85cd554aafc7524e9aaabe73c18a4c1
List of 58 Parkinsonâs disease-associated genetic variants proximal to the 407 DEGs. (XLSX 12Â kb) -
Additional file 1: Table S1. of DeSigN: connecting gene expression with thera...
List of sensitive and resistant cell lines for each of the 140 drugs in DeSigN. (XLS 88Â kb) -
Drug voyager: a computational platform for exploring unintended drug action
Abstract Background The dominant paradigm in understanding drug action focuses on the intended therapeutic effects and frequent... -
Meta-analysis of human gene expression in response to Mycobacterium tuberculo...
Background With the global emergence of multi-drug resistant strains of Mycobacterium tuberculosis, new strategies to treat tuberculosis are urgently needed such as therapeutics... -
SPIDR: small-molecule peptide-influenced drug repurposing
Background Conventional de novo drug design is costly and time consuming, making it accessible to only the best resourced research organizations. An emergent approach to new... -
A two-tiered unsupervised clustering approach for drug repositioning through ...
Background Drug repositioning is the process of identifying new uses for existing drugs. Computational drug repositioning methods can reduce the time, costs and risks of drug...
